A systematic approach facilitates formulation component selection.
Xiaoya Ding, PhD
Advertisement
Xiaoya Ding, PhD, is the director of scientific and technical affairs at the cGMP laboratory, PPD, Inc.
Articles by Xiaoya Ding, PhD
Two case studies illustrate a systematic approach.
With the advent of high-resolution mass spectrometers and highly sensitive MS instruments, vaccine characterization has entered a new phase.
Advertisement
Latest Updated Articles
A Study of Leachables for Biopharmaceutical Formulations Stored in Rubber-Stoppered Glass VialsPublished: April 1st 2010 | Updated:
Extractables and Leachables Study Approach for Disposable Materials Used in BioprocessingPublished: February 1st 2008 | Updated:
Vaccine Characterization Using Advanced TechnologyPublished: August 2nd 2007 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
